Guidelines versus clinical practice—which therapy and which device?
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Respiratory Medicine
- Vol. 98, S28-S34
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The ideal inhaler: design and characteristics to improve outcomesRespiratory Medicine, 2004
- Dose-related effect of inhaled fluticasone on allergen-induced airway changes in ratsEuropean Respiratory Journal, 2002
- Scintigraphic comparison of budesonide deposition from two dry powder inhalersEuropean Respiratory Journal, 2000
- Drug Delivery from the Turbuhaler and Nebuhaler Pressurized Metered Dose Inhaler to Various Age Groups of Children with AsthmaJournal of Aerosol Medicine, 1999
- Asthmatherapie bei Kindern und ErwachsenenMedizinische Klinik, 1998
- Lung Deposition of Fenoterol and Flunisolide Delivered Using a Novel Device for Inhaled MedicinesChest, 1998
- Lung Delivery of Salbutamol Given by Breath Activated Pressurized Aerosol and Dry Powder Inhaler DevicesPulmonary Pharmacology & Therapeutics, 1997
- Guidelines for management of asthma in adults: II--Acute severe asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign.BMJ, 1990
- Guidelines for management of asthma in adults: I--Chronic persistent asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign.BMJ, 1990
- Bioequivalent doses of budesonide and prednisone in moderate and severe asthmaJournal of Allergy and Clinical Immunology, 1989